Parental Vaccine Hesitancy Among Former Refugees in Aotearoa New Zealand

About this item

Title

Parental Vaccine Hesitancy Among Former Refugees in Aotearoa New Zealand

Content partner

Auckland University of Technology

Collection

Tuwhera

Description

Background: Vaccination is one of the most cost-effective and successful public health measures to prevent and control infectious diseases. Vaccine hesitancy is an important factor underpinning suboptimal vaccination uptake worldwide. Low immunisation uptake contributes to the resurgence of vaccine-preventable diseases (VPDs). Hence, the historic achievements of vaccinations in reducing the burden of VPDs have been threatened. There is substantial evidence on the magnitude and determinants of...

Read more

Format

Research paper

Research format

Thesis

Thesis level

Masters

Date created

2022

Creator

Senbeta Debela, Mulisa

URL

https://openrepository.aut.ac.nz/handle/10292/14980

Related subjects

Vaccine Hesitancy / Parent Attitudes about Childhood Vaccines / Former Refugees / Parents / New Zealand / Cross-sectional Study

What is the copyright status of this item?

All Rights Reserved

This item is all rights reserved, which means you'll have to get permission from Auckland University of Technology before using it.

More Information

Auckland University of Technology has this to say about the rights status of this item:

OpenAccess

What can I do with this item?

You must always check with Auckland University of Technology to confirm the specific terms of use, but this is our understanding:

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying

You are not allowed to adapt or remix this item into any other works.

No commercial use

You may not use this item commercially.